Citation Impact
Citing Papers
Comparison of the Effects of Three Forms of Individualized Education on Asthma Knowledge in Asthmatic Patients
2002
Inadequate erythropoietin response to anemia: definition and clinical relevance
1994
Adherence to HAART Regimens
2003
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Patient adherence to medical treatment: a review of reviews
2007
Recent insights into antiphospholipid antibody-mediated thrombosis
1999
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Elastomeric high‐mineral content hydrogel‐hydroxyapatite composites for orthopedic applications
2008 StandoutNobel
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
2004
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
“Real-world” effectiveness of daily controller medicine in children with mild persistent asthma
2003
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Interventional tools to improve medication adherence: review of literature
2015
Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors
1998
Infections in adults undergoing unrelated donor bone marrow transplantation
1999
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
GRADE guidelines: 7. Rating the quality of evidence—inconsistency
2011 Standout
Acute graft-vs-host disease
2001
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
Drug-Induced Hepatotoxicity
2003 Standout
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Determinants of prognosis in late chronic-phase chronic myelogenous leukemia.
1998
Osteoporosis: now and the future
2011 Standout
Vascular disorders of the liver # †
2008 Standout
Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count
1999
Chronic graft-versus-host disease
2003 Standout
Chronic myelogenous leukemia: A review
1996
Asthma
2017 Standout
Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
2005
Autologous hemopoietic stem cell transplantation. A possible cure for rheumatoid arthritis?
1997
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens
2001
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
2006 Standout
Pharmacokinetics of Once-Daily IV Busulfan as Part of Pretransplantation Preparative Regimens: A Comparison with an Every 6-Hour Dosing Schedule
2007
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Medical costs of osteoporosis in the elderly Medicare population
2010
Review of Contemporary Irrigant Agitation Techniques and Devices
2009 Standout
Graft-versus-host disease
2009 Standout
The pathobiology of mucositis
2004 Standout
Chemotherapy-induced lung disease
2004
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Adherence
2012
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Tutorial in biostatistics: competing risks and multi‐state models
2006 Standout
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Plotting summary predictions in multistate survival models: Probabilities of relapse and death in remission for bone marrow transplantation patients
1993
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging
2009 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
2004
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
Hepatitis C Virus Infection and Bone Marrow Transplantation: A Cohort Study With 10–Year Follow–Up
1999
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis
2007
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity
2003
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study
2002
Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment
2003
Individualized asthma self-management improves medication adherence and markers of asthma control
2009
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Aspects Concerning Busulfan Pharmacokinetics and Bioavailability
1996
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women
2009 Standout
Prevention of falls and consequent injuries in elderly people
2005 Standout
Anemia of Chronic Disease
2005 Standout
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Adherence to Medication
2005 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Helping patients to master correct inhaler techniques: nursing role
2001
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Methodology for Estimating Current and Future Burden of Osteoporosis in State Populations: Application to Florida in 2000 through 2025
2003
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors
2004
Interventions for enhancing medication adherence
2008 Standout
British Guideline on the Management of Asthma
2008
IL-7 Induces Immunological Improvement in SIV-Infected Rhesus Macaques under Antiviral Therapy
2006 StandoutNobel
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
2006 Standout
Unrelated donor marrow transplantation in children
1995
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Interventions for enhancing medication adherence
2014 Standout
Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2- incompatible transplanted SCID mice
1994
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Annexins: From Structure to Function
2002 Standout
Cytokine dysregulation and acute graft-versus-host disease
1992
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
1994
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Vascular Calcification
2004 Standout
Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications
2001 Standout
Chromosomal analysis of bone marrow stromal fibroblasts in allogeneic HLA compatible sibling bone marrow transplantations
1987
Being surveyed can change later behavior and related parameter estimates
2011 StandoutNobel
Works of K Downs being referenced
Healthcare Use among U.S. Women Aged 45 and Older: Total Costs and Costs for Selected Postmenopausal Health Risks
1999
GM‐CSF after allogeneic bone marrow transplantation: accelerated recovery of neutrophils, monocytes and lymphocytes*
1991
Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients
1990
Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney
1993
The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation
2008
Clinical analysis of 125 patients with the lupus anticoagulant
1993
Apical Pressures Developed by Needles for Canal Irrigation
2002
Inhaled Corticosteroids for Asthma Therapy
2000
Autologous blood stem cell transplantation for haematological malignancy: treatment‐related mortality of 2%
1995
Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
1992
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2
1992
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.
1993
Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
1995
Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2
1992
Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
1990
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
1996
Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease.
1987